Search

everythinglearnresearchcommunity

for

Search:↓

Combining a GnRH agonist with a low-dose oral contraceptive is more effective and safer for treating hirsutism than using either alone.

Dutasteride is approved to help manage prostate enlargement.

GD-23 reduces anxiety by relying on neurosteroid production.

Changing the 6-position on benzopyran molecules affects insulin release, with some compounds showing strong inhibitory effects.

Dutasteride shows promise as a potential treatment for Parkinson's disease.

Lower DHT and higher testosterone levels increase brain activation but don't change behavior in heavy drinkers.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

Tolterodine Tartrate effectively treats overactive bladder symptoms.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Blocking GABA(A) receptors increases neuron sensitivity, showing GABA and glycine have different roles in pain.

New targets for making and using brain-synthesized steroids could lead to better treatments for brain disorders and alcoholism.

Prostaglandin F2α analogs show promise for treating certain types of hair loss but need more research for other skin conditions.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

A neurosteroid can reduce caffeine-induced anxiety in rats.

AC-5216 reduces anxiety in mice through neurosteroids affecting GABAA receptors.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

Liposomal anthracyclines are effective and safer for treating multiple myeloma, especially in elderly patients.

New treatments for Hepatitis C show promise but need more research to confirm their safety and effectiveness for clinical use.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Certain proteins might predict surgical success in trigeminal neuralgia treatment.

Weak endocrine disruptors in mixtures can have significant effects and should be considered in risk assessments.

New pregnane derivatives were more effective than finasteride at inhibiting a key enzyme for male pattern baldness.

Propranolol combined with injections caused skin changes in guinea pigs but didn't fully mimic psoriasis.

PTH-CBD agonists may help regrow hair after chemotherapy.

Researchers created a skin patch that delivers two drugs for treating enlarged prostate, which may improve patient use and dosage control.

Blocking a protein called prostaglandin D2 might help treat hair loss.

Rizatriptan benzoate-loaded dissolving microneedles are effective and convenient for treating acute migraines.

Targeting Vδ1+T-cells may help treat alopecia areata.

ALRV5XR significantly improves hair density in women with hair loss and is well-tolerated.

Deoxycorticosterone and its metabolites help prevent seizures by interacting with specific receptors.